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Dear Editor, 
 
Measles is a highly infectious and contagious disease of the respiratory system caused by 
Morbilivirus which belongs to family Paramyxoviridae (Hashiguchi et al., 2011). The disease 
is a common cause of childhood morbidity and mortality across the globe, particularly in de-
veloping countries and has been characterized by high fever, cough, conjunctivitis, coryza, 
malaise and maculopapular rash along with erythematous patches throughout the body (El-
lison, 1931; Yanagi et al., 2006; Fazlalipour et al., 2008). Measles infection has been con-
trolled by introduction of live attenuated measles vaccine in United States and Europe (Gin-
dler et al., 2004). However, measles is still affecting the developing countries due to insuffi-
cient coverage and improper handling of vaccines (Poland and Jocobson, 1994; Muscat et al., 
2009). Historically, immunization against vaccine preventable diseases (VPDs) in children 
has been started by WHO in 1974, and it was initiated in Pakistan during 1978 (Ali, 2000; 
Bugvi et al., 2014). In general the vaccine coverage against VPDs in Pakistan ranged between 
56 to 88 % which significantly varied among various Provinces (Sheikh et al., 2011).  
Recently, increased number of measles outbreaks with high morbidity and mortality has 
been observed in various regions of Pakistan during recent years (Khan and Khan, 2012; 
Khan and Qazi, 2014). These particular episodes of higher incidence of measles were started 
in Thatta, Mirpurkhas and Jacobabad Districts of Sindh Province by the end of 2012, which 
later on spread towards Punjab Province (Khan and Khan, 2012; Khan and Qazi, 2014). The 
spread of measles was reported to be higher in both rural as well as developed cities of Paki-
stan along with high incidence of mortality and morbidity (Khan and Qazi, 2014). The im-
portant factors considered for these outbreaks were associated with vaccination failure due to 
several reasons i.e. low vaccination coverage, malnutrition and vitamin-A deficiencies, poor 
vaccination facilities in remote and rural areas, mis-handling of vaccines and lack of immun-
ization awareness among parents due to lower levels of education in various areas of country 
(Cohen et al., 2009; Khan and Khan, 2012; Khan and Qazi, 2014). To combat the situation 
extensive supplementary immunization activities have been initiated which targets the chil-
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dren less than 10 years of age particularly in Punjab, Pakistan under Expanded Program on 
Immunization (EPI).  
Therefore, in the current investigation, impact of supplementary vaccination has been es-
timated in children from Faisalabad and Jhang using enzyme linked Immunosorbent assay 
(ELISA) as outlined in supplemental material. A total of 871/1053 (82.71 %) children from 
Faisalabad and 647/813 (79.58 %) children from Jhang were found vaccinated either with 
single or dual dose of measles vaccination (Table 1). Out of these 264 blood samples from 
vaccinated and 100 samples from non-vaccinated children were collected randomly and ana-
lysed for the presence of anti-measles IgG antibodies. Only 73.48 % of vaccinated children 
developed humoral immune response as detected through ELISA. This indicated that the pro-
tection against measles was not optimum according to WHO standards (Rabenau et al., 2007; 
Fazlalipour et al., 2008; Lauridan and van Damme, 2007). Sero conversion following vaccina-
tion against measles in developing countries has been reported to be lower (75 %) due to cer-
tain factors as described previously (Fowotade et al., 2013; Shah et al., 2012). The highest 
values (95 %) for measles vaccination have been reported in European countries (Tischer and 
Gerike, 2000). 
Samples from non-vaccinated children showed high prevalence (63 %) which was an in-
dication of previous measles infection in these particular children. These findings were sug-
gestive and may be correlated with confirmatory sero-diagnosis of recent outbreaks in these 
areas. The non-vaccination status against measles was considered as one of the major risk fac-
tor in children (Khan and Qazi, 2014).  
The prevalence of anti-measles IgG antibodies from samples collected from Faisalabad 
was found 79.54 % whereas in Jhang 67.42 % of samples were observed as positive. There 
was no significant difference of sero-prevalence between Faisalabad and Jhang. The possible 
explanation for non-significant prevalence could be that these two areas are closely related 
geographically, traditionally and are closely situated to each other. These factors may be con-
sidered for a similar trend towards vaccination coverage and sero-conversion against measles 
as previously described by Hussain et al. (2008).  
The prevalence of anti-measles IgG antibodies from samples collected from male children 
was higher as compared to female children with non-significant difference. However, few of 
the available literature has reported that risk of measles and level of anti-measles IgG antibod-
ies was observed higher in females as compared to male children (Rahim et al., 2011; 
Fowotade et al., 2013; Bugvi et al., 2014). Therefore, from the current findings, it may be 
concluded that gender has no relation with associated risk factors of measles.  
Based on various age groups, prevalence of anti-measles IgG antibodies were observed as 
75.35 % in children from 1-6 years of age, whereas 67.56 % in children from 6-10 years of 
age were positive with no significant difference. These findings were not in accordance with 
some of the previous studies which showed the highest incidence of measles during the age of 
6 months to 3 years (Matsumura et al., 2005; Rahim et al., 2011). The possible explanation 
for the observed trend in the current investigation might be due to recent outbreaks during 
2012-13 as previously reported (Khan and Qazi, 2014) or very extensive SIAs during 2013 
against measles which possibly resulted in development of increased humoral immune re-
sponse in children up to the age of 10 years. 
It was concluded from the overall results of present study that vaccination coverage 
against measles was below the standards of WHO and Health Department, Govt. of Punjab, 
Pakistan. Further, vaccine efficacy and development of humoral immune response in children 
was not optimum according to WHO guidelines and higher risk of measles incidence was 
found in non-vaccinated children. Based on these findings, it is recommended that routine 
immunization against all vaccine preventable diseases in general and against measles in par-
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ticular should be carried out as per guidelines of WHO to completely control and eradicate 
measles from Pakistan. 
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Table 1: Vaccination coverage and prevalence of anti-measles IgG antibodies in vaccinated and non-
vaccinated children of Faisalabad and Jhang, Pakistan 
Groups 
No. of children surveyed Prevalence of anti-measles IgG antibodies 
surveyed vaccinated non-vaccinated vaccinated
IgG  
positive 
non-
vaccinated 
IgG  
positive 
Area 
Faisalabad 1053 871 182 132 105 50 25 
Jhang 813 647 166 132 89 50 38 
total 1866 1518 348 264 194 100 63 
Gender 
Male 910 778 132 156 114 70 42 
Female 956 740 216 108 80 30 21 
total 1866 1518 348 264 194 100 63 
Age 
1-6 Years 1008 865 142 104 85 38 22 
6-10 Years 858 653 206 160 109 62 41 
total 1866 1518 348 264 194 100 63 
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